Carregant...
Hepatitis C virus vaccine design: focus on the humoral immune response
Despite the recent development of safe and highly effective direct-acting antivirals, hepatitis C virus (HCV) infection remains a significant health problem. In 2016, the World Health Organization set out to reduce the rate of new HCV infections by 90% by 2030. Still, global control of the virus doe...
Guardat en:
| Publicat a: | J Biomed Sci |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7338099/ https://ncbi.nlm.nih.gov/pubmed/32631318 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12929-020-00669-4 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|